Israel - English - Ministry of Health

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 10000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - aprotinin 2250 kiu/ml - 3750 kiu/ml; factor xiii 1.2 iu/ml - 10 iu/ml; fibrinogen 72 mg/ml - 110 mg/ml; calcium chloride dihydrate 0.036 mmol/ml - 0.044 mmol/ml; thrombin 3.2 iu/ml - 5 iu/ml - topical solution - 4 iu - active: aprotinin 2250 kiu/ml - 3750 kiu/ml factor xiii 1.2 iu/ml - 10 iu/ml fibrinogen 72 mg/ml - 110 mg/ml excipient: albumin histidine nicotinamide polysorbate 80 sodium citrate dihydrate water for injection active: calcium chloride dihydrate 0.036 mmol/ml - 0.044 mmol/ml thrombin 3.2 iu/ml - 5 iu/ml excipient: albumin sodium chloride water for injection - artiss is indicated for use in adhering autologous skin grafts in burn patients. artiss is not indicated for haemostasis.

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - aprotinin acetate; calcium chloride dihydrate; human fibrinogen; human thrombin - solutions for sealant - calcium chloride dihydrate 40 mcmol/ml; human thrombin 500 iu / 1 ml; aprotinin acetate 3000 kiu / 1 ml; human fibrinogen 91 mg / 1 ml - combinations - supportive treatment in adults and children from 1 month of age where standard surgical techniques appear insufficient: * for improvement of hemostasis.* as a tissue glue to improve wound healing or to support sutures in vascular surgery and in gastrointestinal anastomoses.* for tissue sealing, to improve adhesion of the separated tissue (e.g. tissue flaps, grafts, split skin grafts [mesh grafts]).efficacy in fully heparinized patients has been proven.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 100,000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - human fibrinogen; human thrombin; calcium chloride; aprotinin - solution for sealant - 4 ml - local hemostatics; tissue adhesives

Singapore - English - HSA (Health Sciences Authority)

united italian trading corporation (private) limited - streptokinase - injection, powder, for solution - 1500000 iu/vial

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - injection - see ingredients - each 10 ml solution contains aprotinin 100 000 kiu

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - injection - see ingredients - each 10 ml solution contains aprotinin 200 000 kiu

United States - English - NLM (National Library of Medicine)

puretek corporation - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen tablets are indicated for: the relief of the signs and symptoms of: - rheumatoid arthritis - osteoarthritis - ankylosing spondylitis - polyarticular juvenile idiopathic arthritis - tendonitis - bursitis - acute gout the management of: - pain - primary dysmenorrhea naproxen tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [ see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [ see warnings and precautions (5.7, 5.8) ] - in the setting of coro

Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - aprotinin (synthetic) (for sealer protein solution); calcium chloride (for thrombin solution); human fibrinogen (clottable protein) (for sealer protein solution); human thrombin (for thrombin solution) - solution - aprotinin (synthetic) (for sealer protein solution) 2250 – 3750 kiu/ml; calcium chloride (for thrombin solution) 36 – 44 μmol/ml; human fibrinogen (clottable protein) (for sealer protein solution) 72 – 110 mg/ml; human thrombin (for thrombin solution) 3.2– 5.0 iu/ml